HHealth Read More Early BioNTech mRNA breast cancer trial delivers surprise in longtime disease controlFebruary 24, 2026 Triple-negative breast cancer is regarded as one of the most aggressive forms of the disease. Because tumour cells…
HHealthcare Read More Here Are 2 With Even More Upside AheadOctober 8, 2025 On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to…